Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915194 · ClinicalTrials.gov registry record · NA
SMART Pilot Trial of Glycemic Screening Outreach
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT06915194 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 102 participants.
The verdict
NCT06915194, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
Approximately 130 million Americans have prediabetes or type 2 diabetes (T2D) but remain unscreened and/or unaware of their diagnosis. While prediabetes/T2D screening, also known as glycemic screening, is endorsed in national guidelines, there is almost no research on how to increase screening rates, or evaluations of interventions testing the effectiveness of screening promotion strategies. The American Medical Association has published prediabetes quality measures that apply to UCLA Health as well as all other health systems, specifically tracking the percentage of adult patients with risk factors for T2D due for glycemic screening for whom the screening process was initiated. However, there is no current systemic effort underway at UCLA, or most other health systems, to encourage glycemic screening. We are proposing a pilot trial of the first SMART (Sequential Multiple Assignment Randomized Trial) for glycemic screening. Our SMART experiment will provide preliminary feasibility and acceptability data for a larger, multisite trial that will provide vital guidance to optimize screening approaches for a growing number of screening-eligible patients so that they may seek earlier detection, treatment, and/or access to lifestyle programs and interventions for T2D or prediabetes.
Interventions
- BEHAVIORAL Text message
- BEHAVIORAL Patient portal message
- BEHAVIORAL Mailed letter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2025-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915194
The ClinicalTrials.gov registry entry for NCT06915194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Text message is the first listed.
NCT06915194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06915194 about?
NCT06915194 is a clinical study titled "SMART Pilot Trial of Glycemic Screening Outreach". Approximately 130 million Americans have prediabetes or type 2 diabetes (T2D) but remain unscreened and/or unaware of their diagnosis. While prediabetes/T2D screening, also known as glycemic screening, is endorsed in national guidelines, there is almost no research on how to increase screening rates...
What is the current status of trial NCT06915194?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2025-07-08. Estimated completion is 2025-11-08.
What interventions are being tested in trial NCT06915194?
The interventions under investigation include: Text message (BEHAVIORAL), Patient portal message (BEHAVIORAL), Mailed letter (BEHAVIORAL).
Who is sponsoring clinical trial NCT06915194?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.